Evidence map›Paper›PMID 22569735›Full record

ArticleJournal of materials science. Materials in medicine2012

Thermosensitive hydrogel of hydrophobically-modified methylcellulose for intravaginal drug delivery.

Ning Li, Meihua Yu, Liandong Deng, Jun Yang, Anjie Dong

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of materials science. Materials in medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Nanotechnology-based antiviral therapeutics.Drug delivery and translational research · 2021
    Review
  3. Review
  4. Article
  5. Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.Journal of nanotechnology and materials science · 2017
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ning LiDepartment of Polymer Science and Technology, School of Chemical Engineering and Technology, Tianjin University, Nankai District, Tianjin, People's Republic of China.
Meihua Yu
Liandong Deng
Jun Yang
Anjie Dong
Tianjin University · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrogels with the advantages of prolonging drug release and administration convenience are necessary for intravaginal drug delivery to prevent sexual transmission of human immunodeficiency virus and other vaginal infections. In this study, the thermosensitive hydrogel of methylcellulose modified by stearic acid (MCS) were evaluated in the presence of NaCl and phosphates, which exhibited sol-to-gel transition performance at body temperature or even lower. The in vitro cytotoxicity and in vivo mucosal irritation were investigated and the results showed that MCS hydrogel possessed good biocompatibility similar with hydroxyethyl cellulose (HEC) gel. Significantly, the release studies revealed that MCS hydrogel could control tenofovir sustained release for 10 h without burst release, longer than that from HEC gel or poloxamer 407 hydrogel. Therefore, MCS thermosensitive hydrogel would be a promising carrier for intravaginal delivery of antiviral drugs for long time controlled release.

Indexed as

AdenineAdministration, IntravaginalAnimalsAnti-HIV AgentsCells, CulturedDelayed-Action PreparationsDiffusionFemaleHot TemperatureHydrogelsHydrophobic and Hydrophilic InteractionsMaterials TestingMethylcelluloseOrganophosphonatesRabbitsTenofovirAdenineAnti-HIV AgentsDelayed-Action PreparationsHydrogelsMethylcelluloseOrganophosphonatesTenofovir

Identifiers

PMID22569735
OpenAlexW1992327585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.